Pharming Group

Pharming Group EBIT per Share

The EBIT per Share of Pharming Group (PHAR) as of Oct 14, 2026 is 0.28 USD. In the previous year, EBIT per Share was -0.01 USD — a change of -2,200.29% (higher).

EBIT per Share

0.28USD

YoY

-2,200.29%

Last updated:

EBIT per Share of Pharming Group is 2025 0.28 USD. EBIT per Share of Pharming Group was 2024 -0.01 USD. It decreases by -2,200.29% higher compared to the previous year.

The Pharming Group EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
-0.01 USD
Jan 1, 2024
-0.01 USD
Jan 1, 2025
0.28 USD
Jan 1, 2026 (e)
0.41 USD
Jan 1, 2027 (e)
0.38 USD
Jan 1, 2028 (e)
0.58 USD
Jan 1, 2029 (e)
0.69 USD
Jan 1, 2030 (e)
1.03 USD
The Pharming Group EBIT per Share history
YEAREBIT per ShareYoY
est1.03USD+49.62%
est0.69USD+19.38%
est0.58USD+52.00%
est0.38USD-7.32%
est0.41USD+49.11%
0.28USD-2,200.29%
-0.01USD+63.46%
-0.01USD-103.05%
0.26USD+20.13%
0.22USD-81.60%
1.19USD+41.47%
0.84USD+69.77%
0.50USD+56.93%
0.32USD-255.96%
-0.20USD-15.84%
-0.24USD-535.85%
0.06USD-136.22%
-0.15USD-90.10%
-1.54USD-47.94%
-2.96USD-49.07%
-5.81USD-79.07%
-27.76USD-21.88%
-35.54USD+77.17%
-20.06USD-8.56%
-21.93USD—
Access this data via the Eulerpool API
Get Free API Key

Pharming Group Stock analysis

What does Pharming Group do? Pharming Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharming Group stock

EBIT per Share of Pharming Group is 0.28 USD in 2025.

EBIT per Share of Pharming Group changed from -0.01 USD to 0.28 USD, representing a -2,200.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Pharming Group since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Pharming Group

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Pharming Group